A new daily treatment for those suffering from severe dust mite allergies is set to change lives, with a recommendation from the National Institute for Health and Care Excellence (NICE). The tablet, called Acarizax, has shown significant promise in reducing allergy symptoms and is expected to help thousands of people in the UK. The drug has been hailed as an effective solution for those whose symptoms are not adequately managed by standard treatments like antihistamines and steroid nasal sprays.

Dr. Helen Evans-Howells, a GP in Bournemouth and expert in allergies, emphasized that the clinical evidence strongly supports Acarizax as a successful treatment for those battling symptoms such as fatigue, congestion, and facial swelling. This new therapy is particularly beneficial for individuals aged 12 to 65, who suffer from moderate-to-severe house dust mite allergic rhinitis.

Acarizax works by boosting the body’s resistance to dust mites, offering long-term relief. NICE’s review of clinical trials confirmed its effectiveness, particularly for those who haven’t responded to conventional treatments. The medicine will be available through the NHS in England, providing hope for many who have struggled with chronic, debilitating symptoms.

Experts, including Amena Warner from Allergy UK, also highlighted the convenience of this home-based treatment. With initial specialist consultation, patients can manage their treatment without frequent hospital visits, saving both time and money.